ENTRY       D11491                      Drug
NAME        Selicrelumab (USAN/INN)
FORMULA     C6476H9962N1726O2022S58
EXACT_MASS  146117.3562
MOL_WEIGHT  146208.5125
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYTFT GYYMHWVRQA PGQGLEWMGW INPDSGGTNY
            AQKFQGRVTM TRDTSISTAY MELNRLRSDD TAVYYCARDQ PLGYCTNGVC SYFDYWGQGT
            LVTVSSASTK GPSVFPLAPC SRSTSESTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP
            AVLQSSGLYS LSSVVTVPSS NFGTQTYTCN VDHKPSNTKV DKTVERKCCV ECPPCPAPPV
            AGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVQF NWYVDGVEVH NAKTKPREEQ
            FNSTRFVVSV LTVVHQDWLN GKEYKCKVSN KGLPAPIEKT ISKTKGQPRE PQVYTLPPSR
            EEMTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PMLDSDGSFF LYSKLTVDKS
            RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
            (Light chain)
            DIQMTQSPSS VSASVGDRVT ITCRASQGIY SWLAWYQQKP GKAPNLLIYT ASTLQSGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ ANIFPLTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H140-L214, H153-H209, H232-H'232, H235-H'235, H266-H326, H372-H430, H'22-H'96, H'140-L'214, H'153-H'209, H'266-H'326, H'372-H'430, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-CD40 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of colorectal cancer
TARGET      TNFRSF5 (CD40) [HSA:958] [KO:K03160]
  PATHWAY   hsa04060(958)  Cytokine-cytokine receptor interaction
            hsa04514(958)  Cell adhesion molecules
            hsa04620(958)  Toll-like receptor signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Tumor necrosis factor receptors
                TNFRSF5 (CD40)
                 D11491  Selicrelumab (USAN/INN)
DBLINKS     CAS: 1622140-49-1
            PubChem: 384585467
///
